This compound is primarily used in the synthesis of peptides and pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of molecules with potential therapeutic applications, especially in the fields of oncology and neurology. Its trifluoromethyl group enhances the stability and bioavailability of the final compounds, making it valuable in drug discovery and development. Additionally, it is employed in organic synthesis for creating complex molecules with specific stereochemistry, which is crucial for achieving desired biological activity.